[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:ALLR":3,"prompts:company:0001860657":22,"buybacks:0001860657:12":49,"months:0001860657:36":90,"side:events:0001860657":103,"filings:0001860657":120},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0001860657","Allarity Therapeutics, Inc.","ALLR","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:ALLR","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":50,"data_as_of":51,"checked_at":52,"has_active_program":18,"authorized_total":53,"remaining_total":61,"nearest_expiration":64,"programs":67,"recent_quarters":84,"did_asr":15,"asrs":89},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-09-30","2026-11-17T20:46:02.458122Z",{"value":54,"status":55,"as_of":51,"source":56},5000000,"reported",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"0001437749-26-036661","10-Q","2026-11-13","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F1860657\u002F000143774926036661\u002F",{"value":62,"status":55,"as_of":51,"source":63},4928833,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":65,"status":55,"as_of":51,"source":66},"2027-03-01",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},[68],{"authorized":69,"unit":71,"authorized_as_stated":72,"price_as_of":14,"date_authorized":74,"expiration_date":77,"remaining":79,"remaining_as_stated":81,"description":83},{"value":54,"status":55,"as_of":51,"source":70},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"usd",{"value":54,"status":55,"as_of":51,"source":73},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":75,"status":55,"as_of":51,"source":76},"2026-02-26",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":65,"status":55,"as_of":51,"source":78},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":62,"status":55,"as_of":51,"source":80},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":62,"status":55,"as_of":51,"source":82},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"On February 26, 2026, the board of directors approved a new share repurchase program (\"the 2026 Share Repurchase Plan\"), with authorization to purchase up to $5 million of the Company's outstanding shares of common stock over a twelve-month period ending March 1, 2027.",[85],{"period_start":86,"period_end":51,"shares":87,"avg_price":14,"value_usd":87,"source":88},"2026-07-01",0,{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},[],{"company":91,"data_as_of":51,"items":92},{"cik":6,"name":7,"ticker":8,"exchange":9},[93,96,100],{"period_start":86,"period_end":94,"open_market_shares":87,"total_shares":87,"program_shares":87,"asr_shares":14,"avg_price":87,"value_usd":87,"remaining":62,"remaining_unit":71,"source":95},"2026-07-31",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"period_start":97,"period_end":98,"open_market_shares":87,"total_shares":87,"program_shares":87,"asr_shares":14,"avg_price":87,"value_usd":87,"remaining":62,"remaining_unit":71,"source":99},"2026-08-01","2026-08-31",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"period_start":101,"period_end":51,"open_market_shares":87,"total_shares":87,"program_shares":87,"asr_shares":14,"avg_price":87,"value_usd":87,"remaining":62,"remaining_unit":71,"source":102},"2026-09-01",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"view":104,"sort":105,"total":106,"generated_at":107,"items":108,"next_cursor":14},"all","newest",2,"2026-11-20T09:58:33.467888Z",[109,115],{"id":110,"type":111,"event_date":75,"company":112,"amount_usd":54,"amount_estimated":15,"shares":14,"headline":113,"source":114},"df73ddc1-3d35-5eb7-8ae0-e163bcc15be8","authorization_new",{"cik":6,"name":7,"ticker":8,"exchange":9},"Allarity Therapeutics, Inc. authorizes $5m share repurchase program",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"id":116,"type":111,"event_date":117,"company":118,"amount_usd":54,"amount_estimated":15,"shares":14,"headline":113,"source":119},"be309a41-d263-5626-9a64-58a9efb8fc95","2025-03-03",{"cik":6,"name":7,"ticker":8,"exchange":9},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"company":121,"items":122,"edgar_url":129},{"cik":6,"name":7,"ticker":8,"exchange":9},[123],{"accession":57,"form":58,"filed_at":124,"period_end":51,"url":60,"used_for":125},"2026-11-13T08:05:35Z",[126,127,128],"programs","recent_quarters","remaining_total","https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0001860657"]